Goldman Sachs’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$98.7K Sell
182,264
-772,975
-81% -$418K ﹤0.01% 4884
2025
Q1
$626K Sell
955,239
-651,670
-41% -$427K ﹤0.01% 4130
2024
Q4
$1.64M Buy
1,606,909
+1,538,428
+2,247% +$1.57M ﹤0.01% 3613
2024
Q3
$59.3K Sell
68,481
-1,264,973
-95% -$1.1M ﹤0.01% 4650
2024
Q2
$478K Buy
1,333,454
+700,826
+111% +$251K ﹤0.01% 3982
2024
Q1
$424K Buy
632,628
+372,943
+144% +$250K ﹤0.01% 4060
2023
Q4
$141K Sell
259,685
-1,365,238
-84% -$742K ﹤0.01% 4404
2023
Q3
$975K Buy
1,624,923
+504,701
+45% +$303K ﹤0.01% 3550
2023
Q2
$1.46M Buy
1,120,222
+46,085
+4% +$59.9K ﹤0.01% 3395
2023
Q1
$1.89M Sell
1,074,137
-173,040
-14% -$305K ﹤0.01% 3255
2022
Q4
$3.92M Buy
1,247,177
+53,091
+4% +$167K ﹤0.01% 2812
2022
Q3
$5.85M Sell
1,194,086
-254,573
-18% -$1.25M ﹤0.01% 2532
2022
Q2
$6M Buy
1,448,659
+284,772
+24% +$1.18M ﹤0.01% 2524
2022
Q1
$6.76M Sell
1,163,887
-53,009
-4% -$308K ﹤0.01% 2558
2021
Q4
$9.13M Sell
1,216,896
-427,428
-26% -$3.21M ﹤0.01% 2346
2021
Q3
$14.8M Buy
1,644,324
+90,783
+6% +$818K ﹤0.01% 1965
2021
Q2
$18.6M Sell
1,553,541
-379,921
-20% -$4.55M ﹤0.01% 1792
2021
Q1
$24.2M Sell
1,933,462
-543,652
-22% -$6.81M 0.01% 1551
2020
Q4
$38.7M Buy
2,477,114
+633,779
+34% +$9.89M 0.01% 1124
2020
Q3
$17.4M Buy
1,843,335
+224,124
+14% +$2.12M ﹤0.01% 1567
2020
Q2
$14.5M Buy
1,619,211
+223,515
+16% +$2M ﹤0.01% 1694
2020
Q1
$8.89M Buy
1,395,696
+109,101
+8% +$695K ﹤0.01% 1865
2019
Q4
$10.8M Buy
1,286,595
+22,062
+2% +$185K ﹤0.01% 1998
2019
Q3
$11.4M Buy
1,264,533
+70,518
+6% +$638K ﹤0.01% 1855
2019
Q2
$12.9M Sell
1,194,015
-1,826
-0.2% -$19.7K ﹤0.01% 1836
2019
Q1
$11.4M Sell
1,195,841
-111,179
-9% -$1.06M ﹤0.01% 1934
2018
Q4
$15M Buy
1,307,020
+198,005
+18% +$2.27M ﹤0.01% 1697
2018
Q3
$18.8M Buy
1,109,015
+600,719
+118% +$10.2M ﹤0.01% 1686
2018
Q2
$7.22M Sell
508,296
-190,624
-27% -$2.71M ﹤0.01% 2200
2018
Q1
$13.3M Sell
698,920
-212,592
-23% -$4.04M ﹤0.01% 1768
2017
Q4
$14.9M Buy
911,512
+336,107
+58% +$5.51M ﹤0.01% 1712
2017
Q3
$8.63M Buy
575,405
+475,229
+474% +$7.13M ﹤0.01% 2051
2017
Q2
$881K Buy
100,176
+34,913
+53% +$307K ﹤0.01% 3217
2017
Q1
$339K Sell
65,263
-109,192
-63% -$567K ﹤0.01% 3713
2016
Q4
$532K Buy
174,455
+48,819
+39% +$149K ﹤0.01% 3417
2016
Q3
$582K Buy
125,636
+31,010
+33% +$144K ﹤0.01% 3356
2016
Q2
$548K Buy
94,626
+26,184
+38% +$152K ﹤0.01% 3270
2016
Q1
$414K Sell
68,442
-108,533
-61% -$657K ﹤0.01% 3334
2015
Q4
$1.62M Sell
176,975
-829,405
-82% -$7.57M ﹤0.01% 2625
2015
Q3
$5.68M Buy
1,006,380
+61,155
+6% +$345K ﹤0.01% 1948
2015
Q2
$10.5M Sell
945,225
-108,218
-10% -$1.2M ﹤0.01% 1667
2015
Q1
$16.5M Buy
1,053,443
+335,917
+47% +$5.27M 0.01% 1402
2014
Q4
$10.9M Buy
717,526
+248,973
+53% +$3.79M ﹤0.01% 1569
2014
Q3
$5.05M Sell
468,553
-1,427
-0.3% -$15.4K ﹤0.01% 1973
2014
Q2
$7.18M Buy
469,980
+57,696
+14% +$881K ﹤0.01% 1785
2014
Q1
$7.45M Sell
412,284
-1,121,506
-73% -$20.3M ﹤0.01% 1748
2013
Q4
$21.3M Buy
1,533,790
+208,058
+16% +$2.89M 0.01% 1185
2013
Q3
$13.9M Buy
1,325,732
+1,094,175
+473% +$11.5M 0.01% 1295
2013
Q2
$1.81M Buy
+231,557
New +$1.81M ﹤0.01% 2430